Pan-cancer analysis and experimental validation revealed that prognostic biomarker APOBEC3C may promote M2-type

Wen Yin1, Yirui Kuang2, Zhaoqi Xin2

  • 1Department of Neurosurgery, Xiangya Hospital, Central South University; Xiangya School of Basic Medical Sciences, Central South University, Changsha, Hunan, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China; Cancer Research Institute, Xiangya School of Basic Medical Sciences, Central South University, Changsha, Hunan, China; The NHC Key Laboratory of Carcinogenesis and The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Central South University, Changsha, Hunan, China.